| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.59 | 0.0001 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |